Laudon M - Search Results

1

Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Tian SW, Laudon M, Han L, Gao J, Huang FL, Yang YF, Deng HF. Tian SW, et al. Among authors: laudon m. Acta Pharmacol Sin. 2010 Jul;31(7):775-83. doi: 10.1038/aps.2010.80. Epub 2010 Jun 28. Acta Pharmacol Sin. 2010. PMID: 20581849 Free PMC article.

2

A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease.

He P, Ouyang X, Zhou S, Yin W, Tang C, Laudon M, Tian S. He P, et al. Among authors: laudon m. Horm Behav. 2013 Jun;64(1):1-7. doi: 10.1016/j.yhbeh.2013.04.009. Epub 2013 May 4. Horm Behav. 2013. PMID: 23651610

3

Piromelatine ameliorates memory deficits associated with chronic mild stress-induced anhedonia in rats.

Fu W, Xie H, Laudon M, Zhou S, Tian S, You Y. Fu W, et al. Among authors: laudon m. Psychopharmacology (Berl). 2016 Jun;233(12):2229-39. doi: 10.1007/s00213-016-4272-3. Epub 2016 Mar 23. Psychopharmacology (Berl). 2016. PMID: 27007604

4

NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats.

She M, Deng X, Guo Z, Laudon M, Hu Z, Liao D, Hu X, Luo Y, Shen Q, Su Z, Yin W. She M, et al. Among authors: laudon m. Pharmacol Res. 2009 Apr;59(4):248-53. doi: 10.1016/j.phrs.2009.01.005. Epub 2009 Jan 24. Pharmacol Res. 2009. PMID: 19429466

5

Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats.

She M, Hu X, Su Z, Zhang C, Yang S, Ding L, Laudon M, Yin W. She M, et al. Among authors: laudon m. Eur J Pharmacol. 2014 Mar 15;727:60-5. doi: 10.1016/j.ejphar.2014.01.037. Epub 2014 Jan 30. Eur J Pharmacol. 2014. PMID: 24486392

6

Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice.

Mosińska P, Socała K, Nieoczym D, Laudon M, Storr M, Fichna J, Wlaź P. Mosińska P, et al. Among authors: laudon m. Behav Brain Res. 2016 Jul 1;307:199-207. doi: 10.1016/j.bbr.2016.03.036. Epub 2016 Mar 22. Behav Brain Res. 2016. PMID: 27016427

7

Role of Neu-p11/luzindole in the regulation of insulin signaling pathways and insulin resistance.

Li X, Cai S, Yin W, Hu X, Zhang S, Li Z, Li X, Laudon M. Li X, et al. Among authors: laudon m. Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):485-6. doi: 10.1093/abbs/gmw015. Epub 2016 Mar 29. Acta Biochim Biophys Sin (Shanghai). 2016. PMID: 27025603 Free PMC article. No abstract available.

8

Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats.

Huang L, Zhang C, Hou Y, Laudon M, She M, Yang S, Ding L, Wang H, Wang Z, He P, Yin W. Huang L, et al. Among authors: laudon m. Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2449-56. Eur Rev Med Pharmacol Sci. 2013. PMID: 24089222 Free article.

9

Antinociceptive effects of novel melatonin receptor agonists in mouse models of abdominal pain.

Chen C, Fichna J, Laudon M, Storr M. Chen C, et al. Among authors: laudon m. World J Gastroenterol. 2014 Feb 7;20(5):1298-304. doi: 10.3748/wjg.v20.i5.1298. World J Gastroenterol. 2014. PMID: 24574803 Free PMC article.

10

Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models.

Buendia I, Gómez-Rangel V, González-Lafuente L, Parada E, León R, Gameiro I, Michalska P, Laudon M, Egea J, López MG. Buendia I, et al. Among authors: laudon m. Neuropharmacology. 2015 Dec;99:187-95. doi: 10.1016/j.neuropharm.2015.07.014. Epub 2015 Jul 15. Neuropharmacology. 2015. PMID: 26188145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters